← Back to Discover
Pivotal bioVenture Partners Investment Advisor LLC
Period ended Jun 30, 2026 · Latest filing Aug 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $307,788,414
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- VAXCYTE INC · COM · 92243G108 · shares: $82,862,571
- ARCUTIS BIOTHERAPEUTICS INC · COM · 03969K108 · shares: $33,175,720
- TREVI THERAPEUTICS INC · COM · 89532M101 · shares: $32,500,833
- AVALYN PHARMACEUTICALS INC · COM SHS · 05348Y105 · shares: $31,826,793
- EVOMMUNE INC · COM SHS · 30054Y107 · shares: $25,609,072
- MAPLIGHT THERAPEUTICS INC · COM · 56565P103 · shares: $21,914,225
- OCULIS HOLDING AG · ORDINARY SHARES · H5870P102 · shares: $20,891,688
- BIOAGE LABS INC · COM · 09077V100 · shares: $16,014,197
- IMMUNOME INC · COM · 45257U108 · shares: $15,521,929
- ZENAS BIOPHARMA INC · COM · 98937L105 · shares: $12,455,641
Reported holdings
13 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| VAXCYTE INC | COM | 92243G108 | — | 1,425,470 shares | $82,862,571 |
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | — | 1,265,283 shares | $33,175,720 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 1,742,672 shares | $32,500,833 |
| AVALYN PHARMACEUTICALS INC | COM SHS | 05348Y105 | — | 966,792 shares | $31,826,793 |
| EVOMMUNE INC | COM SHS | 30054Y107 | — | 1,926,943 shares | $25,609,072 |
| MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | — | 611,446 shares | $21,914,225 |
| OCULIS HOLDING AG | ORDINARY SHARES | H5870P102 | — | 1,506,250 shares | $20,891,688 |
| BIOAGE LABS INC | COM | 09077V100 | — | 653,374 shares | $16,014,197 |
| IMMUNOME INC | COM | 45257U108 | — | 732,512 shares | $15,521,929 |
| ZENAS BIOPHARMA INC | COM | 98937L105 | — | 490,766 shares | $12,455,641 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 434,033 shares | $8,020,930 |
| RALLYBIO CORP | COM | 75120L209 | — | 300,579 shares | $4,809,264 |
| RECURSION PHARMACEUTICALS IN | CL A | 75629V104 | — | 595,518 shares | $2,185,551 |